Surgical management of Graves disease in childhood and adolescence: an institutional experience

Surgery

Volumn 140, Issue 6, 2006, Pages 1056-1062

  Sherman, Jonathan ^a   Thompson, Geoffrey B ^a   Lteif, Aida ^a   Schwenk II, W Frederick ^a   van Heerden, Jon ^a   Farley, David R ^a   Kumar, Seema ^c   Zimmerman, Donald ^b   Churchward, Marilyn ^a   Grant, Clive S ^a  

^a MAYO CLINIC   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; CHILD; ENDOCRINE OPHTHALMOPATHY; EYE DISEASE; FEMALE; GRAVES DISEASE; HEAT INTOLERANCE; HUMAN; HYPERTHYROIDISM; HYPOPARATHYROIDISM; LABORATORY TEST; LARYNGEAL NERVE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; NERVE INJURY; PATHOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOIODINATION; SAFETY; SUBTOTAL THYROIDECTOMY; SURGEON; SURGICAL TECHNIQUE; TERTIARY HEALTH CARE; THYROID CANCER; THYROIDECTOMY; THYROTOXICOSIS; TIME SERIES ANALYSIS; TREMOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; MALE; RETROSPECTIVE STUDIES; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 33845567786     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.07.040     Document Type: Article

References (25)

1. Gruneiro-Papendieck L., Chiesa A., Finkielstain G., and Heinrich J.J. Pediatric Graves' disease: outcome and treatment. J Pediatr Endocrinol Metab 16 (2003) 1249-1255
2. Cooper D.S. Antithyroid drugs. N Engl J Med 352 (2005) 905-917
3. Ron E., Doody M.M., Becker D.V., et al. Cancer mortality following treatment for adult hyperthyroidism. JAMA 280 (1998) 347-355
4. Franklyn J.A., Maisonneuve P., Sheppard M., Betteridge J., and Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353 (1999) 2111-2115
5. Dotsch J., Rascher W., and Door H.G. Graves disease in childhood: a review of the options for diagnosis and treatment. Pediatr Drugs 5 (2003) 95-102
6. Raymond J.P., Izembart M., Marliac V., et al. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab 69 (1989) 186-190
7. Pacini F., Gasperi M., Fugazzoli L., et al. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. J Nucl Med 35 (1994) 1418-1422
8. Edmonds C.J., and Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59 (1986) 45-51
9. McClellan D.R., and Francis G.L. Thyroid cancer in children, pregnant women, and patients with Graves' disease. Endocrinol Metab Clin North Am 25 (1996) 27-47
10. Ron E. Cancer risks from medical radiation. Health Phys 85 (2003) 47-59
11. Read Jr. C.H., Tansey M.J., and Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 89 (2004) 4229-4233
12. McIver B., Rae P., Beckett G., and Wilkinson E. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. N Engl J Med 334 (1996) 220-224
13. Tamai H., Nakagawa T., and Fukino O. Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy. Ann Intern Med 92 (1980) 488-490
14. Soreide J.A., van Heerden J.A., Lo C.Y., Grant C.S., Zimmerman D., and Ilstrup D.M. Surgical treatment of Graves' disease in patients younger than 18 years. World J Surg 20 (1996) 794-800
15. Sridama V., and DeGroot L.J. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 87 (1989) 70-73
16. Bartalena L., Marcocci C., Bogazzi F., Panicucci M., Lepri A., and Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321 (1989) 1349-1352
17. Tallstedt L., Lundell G., Torring O., Wallin G., Ljunggren J.G., Blomgren H., and Taube A. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326 (1992) 1733-1738
18. Gwinup G., Elias A.N., and Ascher M.S. Effect on exophthalmos of various methods of treatment for Graves' disease. JAMA 247 (1982) 2135-2138
19. Kurihara H. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy. Thyroid 12 (2002) 265-267
20. Marcocci C., Bruno-Bossio G., Manetti L., et al. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Clin Endocrinol (Oxf) 51 (1999) 503-508
21. Perros P., Crombie A.L., and Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 42 (1995) 45-50
22. Stocker D.J., and Burch H.B. Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinol 28 (2003) 205-212
23. Belfiore A., Garofalo M.R., Giuffrida D., et al. Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab 70 (1990) 830-835
24. Dobyns B.M., Sheline G.E., Workman J.B., Tompkins E.A., McConahey W.M., and Becker D.V. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 38 (1974) 976-998
25. Noguchi S., Yamashita H., Marukami N., Nakayama I., Toda M., and Kawamoto H. Small carcinomas of the thyroid: a long term follow-up of 867 patients. Arch Surg 131 (1996) 187-191